Dermala Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 6

Employees
  • Latest Deal Type

  • Grant

  • Latest Deal Amount

  • $20K

  • Investors

  • 7

Dermala General Information

Description

Developer of skin care products designed to treat prevalent skin diseases. The company's product combines human microbiome science with dermatology and digital health technologies to develop novel consumer products for skin issues as well as offer an application for tracking the treatment outcome and treatment optimization via data analytics, machine learning, and artificial intelligence, enabling individuals to get treatment for skin diseases like acne and eczema and skin conditions like skin aging.

Contact Information

Website
www.dermala.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Other Industries
Biotechnology
Internet Retail
Primary Office
  • 4040 Sorrento Valley Boulevard
  • Suite C
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Dermala Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dermala Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 10-Jan-2022 $20K 00.000 Completed Generating Revenue
6. Later Stage VC (Series A) 04-Nov-2020 00.000 00.000 000.00 Completed Generating Revenue
5. Seed Round 02-May-2018 000000 00.00 00.00 Completed Generating Revenue
4. Accelerator/Incubator 02-Aug-2017 00000 Completed Generating Revenue
3. Seed Round 09-Mar-2017 00000 00000 00000 Completed Generating Revenue
2. Seed Round 22-Jul-2015 $250K $250K 00000 Completed Generating Revenue
1. Accelerator/Incubator 01-Dec-2014 Completed Generating Revenue
To view Dermala’s complete valuation and funding history, request access »

Dermala Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed-2 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Seed-1 20,210,185 $0.000100 8% $0.01 $0.01 1x $0.01 22.06%
Seed 5,405,405 $0.000100 8% $0.05 $0.05 1x $0.03 9.95%
To view Dermala’s complete cap table history, request access »

Dermala Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of skin care products designed to treat prevalent skin diseases. The company's product combines human microbio
Personal Products
San Diego, CA
6 As of 2023
00.000
0000000000 00.000

000000

uip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
00000000 00000000
New York, NY
00 As of 0000
00.00
000000&0 00.00

00000

eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo c
00000000 00000000
San Francisco, CA
00 As of 0000
000.00
0000000 0000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dermala Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ZitSticka Formerly VC-backed New York, NY 00 00.00 000000&0 00.00
00000 000 Private Equity-Backed San Francisco, CA 00 000.00 0000000 0000 000.00
00000 & 0000 Private Equity-Backed New York, NY 00 00000 0000000 0000 00000
000000 0000 Venture Capital-Backed Berlin, Germany 000 0000 00000000000 0000
To view Dermala’s complete competitors history, request access »

Dermala Patents

  • 28

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Dermala Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3094315-A1 Skin health tracker Pending 26-Mar-2018 000000000
EP-3776341-A1 Skin health tracker Pending 26-Mar-2018 000000000
EP-3776341-A4 Skin health tracker Pending 26-Mar-2018 000000000
US-20210027897-A1 Skin health tracker Inactive 26-Mar-2018 000000000
US-20200179266-A1 Compositions and methods for preventing, slowing, and reversing skin aging Active 22-May-2017 A61K8/9706
To view Dermala’s complete patent history, request access »

Dermala Executive Team (4)

Name Title Board Seat Contact Info
Lada Rasochova Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Michelle Kem Chief Operating Officer & Senior Director of Product Development
Alex Alim Chief Technology Officer & Director of Technology
You’re viewing 3 of 4 executive team members. Get the full list »

Dermala Board Members (4)

Name Representing Role Since
Asha Nayak Self Board Member 000 0000
Lada Rasochova Ph.D Dermala Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Sara Brand Ph.D True Wealth Ventures Board Member 000 0000
Vlastimil Rasocha Dermala Board Member 000 0000
To view Dermala’s complete board members history, request access »

Dermala Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dermala Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Colgate-Palmolive Corporation 000 0000 000000 0
Cove Fund Growth/Expansion Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Seventure Partners Venture Capital Minority 000 0000 000000 0
True Wealth Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial